Sagent Pharmaceuticals (SGNT) Launches Oxacillin for Injection

Article Stock Quotes (1) Comments (0)

Sagent Pharmaceuticals, Inc. (Nasdaq: SGNT) announced the launch of Oxacillin for Injection, USP, in three latex-free, preservative-free vial presentations. According to IMS data for the twelve-months ended May 2012, the U.S. market for Oxacillin approximated $29 million. As with all products in Sagent's portfolio, Oxacillin features the company's PreventIV MeasuresSM packaging and labeling designed to aid in the reduction of medication errors.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: Senate Takes Aim at Apple (AAPL); Says Irish Unit Earned $22B, Paid $10M in Taxes
• Rosetta Genomics (ROSG) Higher After Credentialing Agreement w/Prime Health
• Paulson in Favor of Amended Plains Exploration (PXP), Freeport (FCX) Merger

Create E-mail Alert Related Categories

Corporate News

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?